Arik Drucker

Halifax, NS, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A large-scale, targeted metabolomics method for the analysis and quantification of metabolites in human plasma via liquid chromatography-mass spectrometry.

A large-scale, targeted metabolomics method for the analysis and quantification of metabolites in human plasma via liquid chromatography-mass spectrometry.

Journal: Analytica chimica acta

Published: June 05, 2023

Profiling non-small cell lung cancer reveals that PD-L1 is associated with wild type EGFR and vascular invasion, and immunohistochemistry quantification of PD-L1 correlates weakly with RT-qPCR.

Profiling non-small cell lung cancer reveals that PD-L1 is associated with wild type EGFR and vascular invasion, and immunohistochemistry quantification of PD-L1 correlates weakly with RT-qPCR.

Journal: PloS one

Published: October 29, 2020

Correction to: Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity.

Correction to: Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity.

Journal: Breast cancer research : BCR

Published: October 23, 2020

Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity.

Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity.

Journal: Breast cancer research : BCR

Published: May 18, 2020

Molecular profiling of non-small cell lung cancer.

Molecular profiling of non-small cell lung cancer.

Journal: PloS one

Published: January 16, 2020

Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients.

Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients.

Journal: PloS one

Published: August 21, 2019

Trastuzumab beyond progression for HER2 positive metastatic breast cancer: progression-free survival on first-line therapy predicts overall survival impact.

Trastuzumab beyond progression for HER2 positive metastatic breast cancer: progression-free survival on first-line therapy predicts overall survival impact.

Journal: The breast journal

Published: July 03, 2014

The utility of BRAFV600E mutation-specific antibody for colon cancers with microsatellite instability.

The utility of BRAFV600E mutation-specific antibody for colon cancers with microsatellite instability.

Journal: Applied immunohistochemistry & molecular morphology : AIMM

Published: May 09, 2014

Ephrin b2 receptor and microsatellite status in lymph node-positive colon cancer survival.

Ephrin b2 receptor and microsatellite status in lymph node-positive colon cancer survival.

Journal: Translational oncology

Published: May 01, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026